These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 20727143

  • 21. Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.
    Zhou M, Geng X, Chen J, Wang X, Wang D, Deng J, Zhang Z, Wang W, Zhang XE, Wei H.
    PLoS One; 2011; 6(11):e27654. PubMed ID: 22102918
    [Abstract] [Full Text] [Related]

  • 22. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y.
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP, Maro A, Pholwat S, Mpagama SG, Gratz J, Liyoyo A, Houpt ER, Kibiki GS, Mmbaga BT, Heysell SK.
    BMC Infect Dis; 2019 Feb 07; 19(1):129. PubMed ID: 30732572
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
    Ei PW, Mon AS, Htwe MM, Win SM, Aye KT, San LL, Zaw NN, Nyunt WW, Myint Z, Lee JS, Aung WW.
    Tuberculosis (Edinb); 2020 Dec 07; 125():102013. PubMed ID: 33142220
    [Abstract] [Full Text] [Related]

  • 30. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Akhmetova A, Kozhamkulov U, Bismilda V, Chingissova L, Abildaev T, Dymova M, Filipenko M, Ramanculov E.
    Int J Tuberc Lung Dis; 2015 Feb 07; 19(2):179-84. PubMed ID: 25574916
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
    Gu Y, Yu X, Jiang G, Wang X, Ma Y, Li Y, Huang H.
    Diagn Microbiol Infect Dis; 2016 Mar 07; 84(3):207-11. PubMed ID: 26775806
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
    Maningi NE, Daum LT, Rodriguez JD, Mphahlele M, Peters RP, Fischer GW, Chambers JP, Fourie PB.
    J Clin Microbiol; 2015 Dec 07; 53(12):3779-83. PubMed ID: 26378284
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Aono A, Chikamatsu K, Yamada H, Kato T, Mitarai S.
    Antimicrob Agents Chemother; 2014 Aug 07; 58(8):4928-30. PubMed ID: 24867972
    [Abstract] [Full Text] [Related]

  • 40. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
    Huang HT, Lin WH, Chan TH, Jou R.
    J Microbiol Immunol Infect; 2023 Dec 07; 56(6):1236-1244. PubMed ID: 37690869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.